---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-23-000085"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:48:27.438321+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Exagen Q2 revenue $14.1M, record AVISE CTD tests; net loss narrows to $5.0M

## Summary
- Revenue $14.1M, up 26% QoQ from $11.2M (Q1 2023) and up from $7.6M (Q2 2022).
- Record 37,749 AVISE CTD tests (+8% YoY); trailing 12-month ASP $320.
- Gross margin 58.7% (Q2 2023) vs 20.1% (Q2 2022); net loss $5.0M vs $14.7M loss a year ago.
- Q3 2023 revenue guidance $10M-$10.5M; cash $31.5M as of June 30, 2023.
- Operating expenses $19.1M, down from $21.7M due to December 2022 headcount reduction.

## SEC filing metadata
- accession: 0001274737-23-000085
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000085/0001274737-23-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000085/exdx-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-23-000085
- JSON: https://secwatch.observer/filing/0001274737-23-000085.json
- Plain text: https://secwatch.observer/filing/0001274737-23-000085.txt

## Key facts
- Earnings Releases
  EXAGEN INC. reported quarter ended June 30, 2023 results: revenue $14.1 million. Guidance initiated.
  - Period: quarter ended June 30, 2023
  - Revenue: $14.1 million
  - Guidance: initiated
  - Result: reported results
  source text: Second Quarter Highlights: • Delivered a record 37,749 AVISE® CTD tests in the second quarter, an 8% increase over the second quarter of 2022. • Recognized total revenue of $14.1 million for the second quarter, a 26% increase over the first quarter of 2023. • Achieved gross margin of 54% in the six months ended June 30, 2023. • AVISE® CTD trailing twelve-month
  evidence_url: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000085/0001274737-23-000085-index.htm
- Earnings Releases
  EXAGEN INC. reported financial results for six months ended June 30, 2023.
  - Period: six months ended June 30, 2023
  - Result: reported results
  source text: On August 7, 2023 , the Company reported its financial results for the three and six months ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000085/0001274737-23-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.